US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist

8.510
+0.180+2.16%

Close May 31 16:00 ET

360.99MMarket Cap-4807P/E (TTM)

Verrica Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

10,240.54%3.83M

-43.27%5.12M

2,823.53%1.99M

-64.94%2.92M

-14.95%182K

-91.42%37K

-24.73%9.03M

68K

8.32M

214K

Operating revenue

10,240.54%3.83M

-43.27%5.12M

2,823.53%1.99M

-64.94%2.92M

-14.95%182K

-91.42%37K

-24.73%9.03M

--68K

--8.32M

--214K

Cost of revenue

1,573.53%1.14M

2.90%746K

338.71%272K

62.65%270K

-37.90%136K

-75.54%68K

725K

62K

166K

219K

Gross profit

8,770.97%2.69M

-47.30%4.38M

28,500.00%1.72M

-67.53%2.65M

1,020.00%46K

-120.26%-31K

-30.78%8.31M

8.15M

-5K

Operating expense

201.60%21.29M

128.36%67.6M

258.94%22.32M

296.18%26.56M

27.93%11.66M

-6.68%7.06M

-31.01%29.6M

-26.60%6.22M

-43.02%6.71M

-15.05%9.12M

Selling and administrative expenses

278.31%16.34M

171.79%47.31M

432.93%17M

410.93%20.05M

14.77%5.94M

-15.61%4.32M

-35.49%17.41M

-37.63%3.19M

-50.97%3.93M

-28.98%5.17M

-General and administrative expense

----

14.77%5.94M

----

-28.98%5.17M

Research and development costs

80.65%4.95M

66.38%20.3M

75.69%5.32M

134.17%6.51M

45.19%5.73M

12.02%2.74M

-23.42%12.2M

-9.80%3.03M

-26.12%2.78M

14.39%3.94M

Operating profit

-162.36%-18.6M

-196.87%-63.22M

-231.65%-20.6M

-1,751.73%-23.92M

-27.35%-11.62M

4.33%-7.09M

31.10%-21.3M

26.67%-6.21M

112.30%1.45M

15.00%-9.12M

Net non-operating interest income expense

-444.20%-1.72M

27.95%-1.22M

-629.02%-1.51M

-1,346.27%-835K

159.85%626K

147.17%500K

59.35%-1.7M

126.73%286K

106.31%67K

-0.19%-1.05M

Non-operating interest income

19.60%598K

475.63%2.74M

176.92%792K

455.41%822K

3,030.00%626K

2,172.73%500K

286.99%476K

959.26%286K

377.42%148K

-39.39%20K

Non-operating interest expense

--2.32M

82.41%3.96M

--2.31M

1,945.68%1.66M

--0

-49.43%2.17M

--0

-92.58%81K

-1.02%1.07M

Other net income (expense)

-11K

-70.64%-2.55M

-35,642.86%-2.5M

96.51%-50K

-1.5M

-7K

-1.43M

-1K

Special income (charges)

----

-76.55%-2.54M

---2.54M

--0

----

---1.44M

--0

---1.44M

----

-Less:Other special charges

----

--1.44M

--0

--1.44M

----

-Gain on sale of property,plant,equipment

----

---2.54M

----

--0

----

Other non- operating income (expenses)

---11K

75.86%-14K

600.00%35K

-1,100.00%-50K

----

---58K

---7K

--5K

---1K

Income before tax

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

13.65%-10.17M

Income tax

Net income

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

13.65%-10.17M

Net income continuous Operations

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

13.65%-10.17M

Minority interest income

Net income attributable to the parent company

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

13.65%-10.17M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

13.65%-10.17M

Basic earnings per share

-193.33%-0.44

-105.56%-1.48

-285.71%-0.54

-26,326.32%-0.54

35.14%-0.24

51.61%-0.15

44.62%-0.72

60.00%-0.14

100.44%0.0021

13.95%-0.37

Diluted earnings per share

-193.33%-0.44

-105.56%-1.48

-285.71%-0.54

-26,339.07%-0.54

35.14%-0.24

51.61%-0.15

44.62%-0.72

60.00%-0.14

100.44%0.0021

13.95%-0.37

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	10,240.54%3.83M	-43.27%5.12M	2,823.53%1.99M	-64.94%2.92M	-14.95%182K	-91.42%37K	-24.73%9.03M	68K	8.32M	214K
Operating revenue	10,240.54%3.83M	-43.27%5.12M	2,823.53%1.99M	-64.94%2.92M	-14.95%182K	-91.42%37K	-24.73%9.03M	--68K	--8.32M	--214K
Cost of revenue	1,573.53%1.14M	2.90%746K	338.71%272K	62.65%270K	-37.90%136K	-75.54%68K	725K	62K	166K	219K
Gross profit	8,770.97%2.69M	-47.30%4.38M	28,500.00%1.72M	-67.53%2.65M	1,020.00%46K	-120.26%-31K	-30.78%8.31M	6K	8.15M	-5K
Operating expense	201.60%21.29M	128.36%67.6M	258.94%22.32M	296.18%26.56M	27.93%11.66M	-6.68%7.06M	-31.01%29.6M	-26.60%6.22M	-43.02%6.71M	-15.05%9.12M
Selling and administrative expenses	278.31%16.34M	171.79%47.31M	432.93%17M	410.93%20.05M	14.77%5.94M	-15.61%4.32M	-35.49%17.41M	-37.63%3.19M	-50.97%3.93M	-28.98%5.17M
-General and administrative expense	----	----	----	----	14.77%5.94M	----	----	----	----	-28.98%5.17M
Research and development costs	80.65%4.95M	66.38%20.3M	75.69%5.32M	134.17%6.51M	45.19%5.73M	12.02%2.74M	-23.42%12.2M	-9.80%3.03M	-26.12%2.78M	14.39%3.94M
Operating profit	-162.36%-18.6M	-196.87%-63.22M	-231.65%-20.6M	-1,751.73%-23.92M	-27.35%-11.62M	4.33%-7.09M	31.10%-21.3M	26.67%-6.21M	112.30%1.45M	15.00%-9.12M
Net non-operating interest income expense	-444.20%-1.72M	27.95%-1.22M	-629.02%-1.51M	-1,346.27%-835K	159.85%626K	147.17%500K	59.35%-1.7M	126.73%286K	106.31%67K	-0.19%-1.05M
Non-operating interest income	19.60%598K	475.63%2.74M	176.92%792K	455.41%822K	3,030.00%626K	2,172.73%500K	286.99%476K	959.26%286K	377.42%148K	-39.39%20K
Non-operating interest expense	--2.32M	82.41%3.96M	--2.31M	1,945.68%1.66M	--0	--0	-49.43%2.17M	--0	-92.58%81K	-1.02%1.07M
Other net income (expense)	-11K	-70.64%-2.55M	-35,642.86%-2.5M	96.51%-50K			-1.5M	-7K	-1.43M	-1K
Special income (charges)	----	-76.55%-2.54M	---2.54M	--0	----	----	---1.44M	--0	---1.44M	----
-Less:Other special charges	----	----	----	----	----	----	--1.44M	--0	--1.44M	----
-Gain on sale of property,plant,equipment	----	---2.54M	----	----	----	----	--0	----	----	----
Other non- operating income (expenses)	---11K	75.86%-14K	600.00%35K	-1,100.00%-50K	----	----	---58K	---7K	--5K	---1K
Income before tax	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K	13.65%-10.17M
Income tax
Net income	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K	13.65%-10.17M
Net income continuous Operations	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K	13.65%-10.17M
Minority interest income
Net income attributable to the parent company	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K	13.65%-10.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K	13.65%-10.17M
Basic earnings per share	-193.33%-0.44	-105.56%-1.48	-285.71%-0.54	-26,326.32%-0.54	35.14%-0.24	51.61%-0.15	44.62%-0.72	60.00%-0.14	100.44%0.0021	13.95%-0.37
Diluted earnings per share	-193.33%-0.44	-105.56%-1.48	-285.71%-0.54	-26,339.07%-0.54	35.14%-0.24	51.61%-0.15	44.62%-0.72	60.00%-0.14	100.44%0.0021	13.95%-0.37
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall